Gunderson Dettmer LLP

Strategic Transactions and Licensing, Data Privacy, Mergers and Acquisitions, Fund Investments in Companies, Life Sciences, Licensing and Strategic Partnering, Seed, Venture and Growth Financings, Life Sciences

Colin is co-head of the Strategic Transactions & Licensing group and is in our San Francisco and Silicon Valley offices.

Colin is a partner in our Silicon Valley office, specializing in the areas of corporate partnering and strategic alliances, technology protection, and licensing and commercialization of intellectual property and technology assets. Colin’s focus is representing emerging growth companies both in the United States and abroad. Additionally, Colin has considerable experience representing venture capitalists and multinational companies requiring such expertise.

Colin represents his clients in negotiating strategic alliances and/or licensing and commercial arrangements with companies such as Amazon, Apple, BMW, Bristol Myers Squibb, Cardinal Health, Chevron Corporation, Cisco, Disney, Exxon-Mobile, Ford, Intel, JP Morgan Chase, Kaiser, Pfizer, Roche, Salesforce.com, Tesla, Thermo Fisher Scientific and Visa. He has also negotiated commercial and clinical arrangements with many major research institutions.

University of Michigan Law School, J.D. University of California, Berkeley, B.A., History and Political Science